<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Personalized Literature Report - ashwin</title>
  <style>
    * { box-sizing: border-box; margin: 0; padding: 0; }
    body {
      font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;
      line-height: 1.6;
      color: #1a1a1a;
      max-width: 800px;
      margin: 0 auto;
      padding: 40px 20px;
    }
    h1 { font-size: 24px; margin-bottom: 8px; color: #111; }
    h2 { font-size: 18px; margin: 24px 0 12px; color: #333; border-bottom: 2px solid #e5e5e5; padding-bottom: 8px; }
    h3 { font-size: 16px; margin: 16px 0 8px; color: #444; }
    p { margin-bottom: 12px; }
    .header { margin-bottom: 32px; }
    .subtitle { color: #666; font-size: 14px; }
    .section { margin-bottom: 24px; }
    .card {
      background: #f8f9fa;
      border-radius: 8px;
      padding: 16px;
      margin-bottom: 16px;
      border-left: 4px solid #4a90d9;
    }
    .card.warning { border-left-color: #f0ad4e; background: #fff9e6; }
    .card.success { border-left-color: #5cb85c; background: #f0fff0; }
    .card.info { border-left-color: #5bc0de; background: #f0f9ff; }
    .card-title { font-weight: 600; margin-bottom: 8px; color: #333; }
    .badge {
      display: inline-block;
      padding: 2px 8px;
      border-radius: 4px;
      font-size: 12px;
      margin: 2px;
    }
    .badge-condition { background: #e8d5f0; color: #6b3d7d; }
    .badge-medication { background: #d5f0e8; color: #2d6b4f; }
    .badge-biomarker { background: #d5e8f0; color: #2d4f6b; }
    .grid { display: grid; grid-template-columns: 1fr 1fr; gap: 16px; }
    .stat { text-align: center; padding: 12px; background: #fff; border-radius: 6px; }
    .stat-value { font-size: 24px; font-weight: 700; color: #333; }
    .stat-label { font-size: 12px; color: #666; text-transform: uppercase; }
    .reason-item {
      padding: 12px;
      background: #fff;
      border-radius: 6px;
      margin-bottom: 8px;
      border: 1px solid #e5e5e5;
    }
    .reason-type {
      font-size: 11px;
      text-transform: uppercase;
      color: #999;
      margin-bottom: 4px;
    }
    .footer {
      margin-top: 40px;
      padding-top: 20px;
      border-top: 1px solid #e5e5e5;
      font-size: 12px;
      color: #666;
    }
    @media print {
      body { padding: 20px; }
      .card { break-inside: avoid; }
    }
  </style>
</head>
<body>
  <div class="header">
    <h1>Personalized Literature Report</h1>
    <p class="subtitle">Generated 2/4/2026</p>
  </div>

  <div class="section">
    <h2>Patient Summary</h2>
    <div class="grid">
      <div class="stat">
        <div class="stat-value">34</div>
        <div class="stat-label">Age</div>
      </div>
      <div class="stat">
        <div class="stat-value">Male</div>
        <div class="stat-label">Sex</div>
      </div>
    </div>

    

    
    <h3>Medications</h3>
    <div>
      <span class="badge badge-medication">atorvastatin calcium 10 MG Oral Tablet</span> <span class="badge badge-medication">SUMAtriptan succinate 50 MG Oral Tablet</span> <span class="badge badge-medication">propranolol HCl 10 MG Oral Tablet</span> <span class="badge badge-medication">ondansetron 4 MG Disintegrating Oral Tablet</span> <span class="badge badge-medication">amoxicillin 875 MG / clavulanate potassium 125 MG Oral Tablet</span> <span class="badge badge-medication">cholecalciferol 1.25 MG (50,000 UNT) Oral Capsule</span> <span class="badge badge-medication">Advil 200 MG Oral Capsule</span> <span class="badge badge-medication">methylPREDNISolone 4 MG Oral Tablet</span> <span class="badge badge-medication">amoxicillin 875 MG / clavulanate potassium 125 MG Oral Tablet</span> <span class="badge badge-medication">Drug or medicament (substance)</span>
      <span class="badge">+1 more</span>
    </div>
    

    
  </div>

  <div class="section">
    <h2>Study Information</h2>
    <div class="card info">
      <div class="card-title">Untitled Study</div>
      <p><strong>Intervention:</strong> evolocumab (either 140 mg every 2 weeks or 420 mg monthly)</p>
      <p><strong>Primary Endpoint:</strong> composite of cardiovascular death, myocardial infarction, stroke, hospitalization for unstable angina, or coronary revascularization</p>
      <p><strong>Follow-up:</strong> 2.2 years median</p>
    </div>
  </div>

  
  <div class="section">
    <h2>Applicability Assessment</h2>
    <div class="card warning">
      <div class="card-title">This study may not directly apply to this patient</div>
      <p>Based on the patient's health records, the findings from this study might not be directly applicable.</p>
    </div>

    
    <h3>Reasons</h3>
    
    <div class="reason-item">
      <div class="reason-type">condition</div>
      <p><strong>Patient does not have required condition: atherosclerotic cardiovascular disease</strong></p>
      <p style="color: #666; font-size: 14px;">The study required patients to have atherosclerotic cardiovascular disease</p>
    </div>
    
    <div class="reason-item">
      <div class="reason-type">medication</div>
      <p><strong>Patient is not on required medication: statin therapy</strong></p>
      <p style="color: #666; font-size: 14px;">The study required patients to be taking statin therapy</p>
    </div>
    
    <div class="reason-item">
      <div class="reason-type">biomarker</div>
      <p><strong>Missing biomarker data: LDL cholesterol</strong></p>
      <p style="color: #666; font-size: 14px;">The study results are based on LDL cholesterol levels, which are not in the patient's records</p>
    </div>
    
    
  </div>
  

  <div class="footer">
    <p><strong>Important:</strong> This personalized summary is based on a research study and health data.
    It is not medical advice. Always discuss treatment decisions with your healthcare provider.
    Individual results may vary from study findings.</p>
    <p style="margin-top: 12px;">Generated by FHIR Literature Personalization Tool</p>
  </div>
</body>
</html>